Literature DB >> 21134433

Ex vivo and in vivo effect of Chinese herbal pill Yi Shen Juan Bi (YJB) on experimental arthritis.

Pathirage Kamal Perera1, Cheng Peng, Lv Xue, Yunman Li, Caifeng Han.   

Abstract

AIM OF THIS STUDY: Chinese herbal pill Yi Shen Juan Bi (YJB), which is a compound herbal drug, has traditionally been used as an anti-rheumatic drug in Chinese local clinics. Thus, we investigated the therapeutic effect of the YJB in rheumatoid arthritis (RA), using Freund's complete induced adjuvant arthritis (AA) in rat model.
METHODS: For that purpose, macrophage derived cytokine tumor necrosis factor alpha (TNF-α) and interleukin-1 (IL-1) were measured in ex vivo by enzyme linked immunosorbent assay (ELISA). We also assayed the effect of YJB on peritoneal macrophage derived nitric oxide (NO) in ex vivo by Griess reaction. Prostaglandin E (PGE) in metapedes was assayed by ultraviolet spectrophotometer method. Further synovial Bax level was examined by Western blot analysis.
RESULTS: YJB significantly decreased the production of peritoneal macrophages derived TNF-α, IL-1 and NO. YJB also significantly decreased prostaglandin E (PGE) and upregulated the Bax expression in AA rat's synovium.
CONCLUSION: YJB is a potential anti-rheumatic agent targeting the inflammatory and immunomodulatory response of macrophages while down regulating the PGE and up-regulating the pro-apoptotic Bax expression. Such characteristics of YJB on AA may be advantageous to the treatment of clinical rheumatoid arthritis.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134433     DOI: 10.1016/j.jep.2010.11.065

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

1.  Investigation of the effect of phlomisoside F on complete Freund's adjuvant-induced arthritis.

Authors:  Xiuying Zhang; Yanfeng Dong; Hanyu Dong; Wen Zhang; Fang Li
Journal:  Exp Ther Med       Date:  2016-12-22       Impact factor: 2.447

2.  Tetrandrine alleviates symptoms of rheumatoid arthritis in rats by regulating the expression of cyclooxygenase-2 and inflammatory factors.

Authors:  Xiang Li; Zhongxiu Wu; Bin He; Wei Zhong
Journal:  Exp Ther Med       Date:  2018-07-20       Impact factor: 2.447

3.  A traditional Chinese medicine versus Western combination therapy in the treatment of rheumatoid arthritis: two-stage study protocol for a randomized controlled trial.

Authors:  Chi Zhang; Miao Jiang; Aiping Lu
Journal:  Trials       Date:  2011-06-04       Impact factor: 2.279

4.  The protective effect of yi shen juan bi pill in arthritic rats with castration-induced kidney deficiency.

Authors:  Hongyan Zhao; Jian Li; Xiaojuan He; Cheng Lu; Cheng Xiao; Xuyan Niu; Ning Zhao; Dahong Ju; Aiping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-05       Impact factor: 2.629

5.  Yi Shen Juan Bi Pill alleviates bone destruction in inflammatory arthritis under postmenopausal conditions by regulating ephrinB2 signaling.

Authors:  Huihui Xu; Li Tao; Jinfeng Cao; Peng Zhang; Hui Zeng; Hongyan Zhao
Journal:  Front Pharmacol       Date:  2022-09-30       Impact factor: 5.988

6.  Predicting and verifying outcome of Tripterygium wilfordii Hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial.

Authors:  Miao Jiang; Qinglin Zha; Chi Zhang; Cheng Lu; Xiaoping Yan; Wanhua Zhu; Wei Liu; Shenghao Tu; Liping Hou; Chengwu Wang; Wandong Zhang; Qinghua Liang; Bing Fan; Jiangping Yu; Weidong Zhang; Xinru Liu; Jing Yang; Xiaojuan He; Li Li; Xuyan Niu; Yan Liu; Hongtao Guo; Bing He; Ge Zhang; Zhaoxiang Bian; Aiping Lu
Journal:  Sci Rep       Date:  2015-04-15       Impact factor: 4.379

7.  Ginsenoside Rg1 attenuates adjuvant-induced arthritis in rats via modulation of PPAR-γ/NF-κB signal pathway.

Authors:  Leiming Zhang; Maojing Zhu; Minmin Li; Yuan Du; Sijin Duan; Yanan Huang; Yongying Lu; Jianqiao Zhang; Tian Wang; Fenghua Fu
Journal:  Oncotarget       Date:  2017-07-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.